Converge Bio has raised $5.5 million in seed funding led by TLV Partners.
WHAT IT DOES
Converge Bio is a generative AI hub for Biotech and Pharma that allows the accelerated discovery and development of drugs that use large language models (LLMs).
The platform supplies a library of foundational models across all biological languages that can be amplified and adjusted for specific tasks with...
